Export 2747 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
W. T. Wong, Liang, K., Hammel, K., Coleman, H. R., and Chew, E. Y., “Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease”, Ophthalmology, vol. 115, pp. 1957-1964, 2008.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., “A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.”, Allergy, vol. 68, no. 6, pp. 803-8, 2013.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., “A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy”, Allergy, vol. 68, pp. 803-808, 2013.
R. A. Wood, Stablein, D., Henning, A. K., Lindblad, R., and Sicherer, S. H., “A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy”, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 129(2), p. AB27.
R. A. Wood, Sicherer, S. H., Vickery, B. P., Jones, S. M., Liu, A. H., Fleischer, D. M., Henning, A. K., Mayer, L., Burks, A. W., Grishin, A., Stablein, D., and Sampson, H. A., “The Natural History of Milk Allergy in an Observational Cohort”, J Allergy Clin Immunol, vol. 131, pp. 805-812, 2013.
R. Wood, Sicherer, S., Stablein, D., Jones, S., Burks, A., Liu, A., Fleischer, D., Leung, D., Lindblad, R., Sampson, H., and CoFAR), Co.F. A. R. (, “Trends in Milk, Egg, and Peanut IgE Levels Over Time in an Observational Study of Infants with Food Allergy (COFAR2): One Year Follow Up”, Washington DC: , 2009.
R. A. Wood, Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., and Sampson, H. A., “A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.”, J Allergy Clin Immunol, vol. 137, no. 4, pp. 1103-1110.e11, 2016.
R. A. Wood, Sicherer, S. H., Vickery, B. P., Jones, S. M., Liu, A. H., Fleischer, D. M., Henning, A. K., Mayer, L., A Burks, W., Grishin, A., Stablein, D., and Sampson, H. A., “The natural history of milk allergy in an observational cohort.”, J Allergy Clin Immunol, vol. 131, no. 3, pp. 805-12, 2013.
S. E Woodle, M First, R., Pirsch, J., Shihab, F., A Gaber, O., and Van Veldhuisen, P., “A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.”, Ann Surg, vol. 248, no. 4, pp. 564-77, 2008.
E. S. Woodle and Group, F. Steroid Wi, “A Prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycopheonlate mofetil therapy with antibody induction”, 2003.
E. S. Woodle, “A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report.”, Transplant Proc, vol. 37, no. 2, pp. 804-8, 2005.
S. Woodle, First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., and P Van Veldhuisen, forthe Astell, “A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy”, Ann Surg, vol. 248, pp. 564-577, 2008.
E. S. Woodle, Cincinnati, Dof Transpl, and Group, F. Steroid Wi, “A Randomized, Double Blind, Placebo Controlled Trial of Early Corticosteroid Cessation vs Chronic Corticosteroid Maintenance Therapy”, in American Transplant Congress (ATC), Philadelphia, PA, 2005.
E. Woodle, Van Veldhuisen, P., and , “A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report”, Transplant Proc, vol. 37, pp. 804-808, 2005.
C. W. Woods, Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., DeRaad, D. E. Poer, Amanna, I. J., Slifka, M. K., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C., and Walter, E. B., “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.”, Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
P. F. Wright, Lambert, J. S., Gorse, G. J., Hsieh, R. H., McElrath, M. J., Weinhold, K., Wara, D. W., Anderson, E. L., Keefer, M. C., Jackson, S., Wagner, L. J., Francis, D. P., Fast, P. E., and McNamara, J., “Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.”, J Infect Dis, vol. 180, no. 4, pp. 1080-8, 1999.
M. Wright, Lindblad, R., Jelstrom, E., King, D., Blumberg, D., Yohannes, P., Yesko, L., Campanella, M., and Saunders, C. A., “Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
J. J. Wright, Blatner, G., and Cheson, B. D., “Clinical trials referral resource. Clinical trials of dolastatin-10.”, Oncology (Williston Park), vol. 13, no. 1, pp. 68-70, 75, 1999.
J. J. Wright, Zerivitz, K., and Schoenfeldt, M., “Clinical trials referral resource. Current clinical trials of bortezomib.”, Oncology (Williston Park), vol. 17, no. 5, pp. 677-80, 683-6, 691-2, 2003.
J. J. Wright, Zerivitz, K., Gravell, A. E., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).”, Oncology (Williston Park), vol. 16, no. 7, pp. 930-1, 935-7, 2002.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341”, Oncology, vol. 14, pp. 1589-15901593-94 1597, 2000.
B. L. Wright, Kulis, M., Orgel, K. A., Burks, A. W., Dawson, P., Henning, A. K., Jones, S. M., Wood, R. A., Sicherer, S. H., Lindblad, R. W., Stablein, D., Leung, D. Y. M., Vickery, B. P., and Sampson, H. A., “Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.”, Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
P. F. Wright, Lambert, J. S., Gorse, G. J., Hsieh, R. H., McElrath, M. J., Weinhold, K., Ware, D. W., Anderson, E. L., Keefer, M. C., Jackson, S., Wagner, L. J., Francis, D. P., Fast, P. E., McNamara, J., and Group, A. I. D. S. Vaccine Ev, “Immunization with envelope MN rap 120 vaccine in human immunodeficiency virus infected pregnant women”, J Infec Dis, vol. 180, pp. 1080-8, 1999.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.”, Oncology (Williston Park), vol. 14, no. 11, pp. 1589-90, 1593-4, 1597, 2000.
J. Wright, Blatner, G. L., and Cheson, B. D., “Clinical trials referral resource. Clinical trials of flavopiridol.”, Oncology (Williston Park), vol. 12, no. 7, pp. 1018, 1023-4, 1998.